Lexicon Pharmaceuticals, Inc.
LXRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | $3 | -$25 | -$34 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $3 | $2 |
| Change in WC | -$14 | $11 | -$19 | $12 |
| Other Non-Cash | $27 | -$1 | -$2 | -$1 |
| Operating Cash Flow | $0 | $17 | -$44 | -$21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$27 | -$27 | -$66 | -$26 |
| Inv. Sales/Matur. | $79 | $41 | $106 | $80 |
| Other Inv. Act. | -$52 | $1 | $1 | $0 |
| Investing Cash Flow | $0 | $15 | $41 | $54 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$45 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$1 | -$0 |
| Financing Cash Flow | $0 | -$45 | -$1 | -$0 |
| Forex Effect | $28 | $0 | $0 | $0 |
| Net Chg. in Cash | $28 | -$13 | -$4 | $32 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $63 | $67 | $35 |
| End Cash | $50 | $50 | $63 | $67 |
| Free Cash Flow | $0 | $17 | -$44 | -$22 |